Erika Hamilton: Reflecting on breast cancer research and the importance of clinical trials
Erika Hamilton posted the following on LinkedIn:
“Many of us can recall a time in our childhood when we were asked what we wanted to be when we grew up. When I was a kindergartner, I already knew the answer (annoying, right?). I wanted to be a doctor, and that passion has only deepened throughout my journey in breast cancer research at Sarah Cannon Research Institute.
As we mark Breast Cancer Awareness Month, I’m sharing my thoughts on the importance of early detection, personalized treatments, and the life-saving role of clinical trials. Breast cancer care has come so far, but there’s still more work to be done to ensure every patient has access to the best breast cancer care possible.
Read my latest article to learn more.”
More posts featuring Erika Hamilton on oncodaily.com
Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee.
She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023